Thrombolytic Science, LLC
5Patents
3Active
5Granted
36Portfolio score
Filing activity: Apr 16, 2004 → Jun 15, 2018 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7074401B2 | Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots | Human Necessities | 6 | Expired |
| US8187592B2 | C1-inhibitor prevents non-specific plasminogen activation by a prourokinase mutant without impeding fibrin-specific fibrinolysis | Chemistry; Metallurgy | 2 | Active |
| US7070958B2 | Methods of making pro-urokinase mutants | Chemistry; Metallurgy | 2 | Expired |
| US11213574B2 | Methods for safe and effective thrombolysis using sequential administration of tissue plasminogen activator and mutant pro-urokinase | Chemistry; Metallurgy | 0 | Active |
| US11154596B2 | Methods for thrombolysis | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.